Showing results (501-510 of 575) with videos related to
Sort By:
Pageof 58
BMC Nutrition|July 24, 2020
End-user perceptions of a patient- and family-centred intervention to improve nutrition intake among oncology patients: a descriptive qualitative analysisAndrea P Marshall, Georgia Tobiano, Shelley Roberts, et al.The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Pharmacological characterization of a novel nonpeptide antagonist radioligand, (+/-)-N-[2-methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for corticotropin-releasing factor1 receptorsGe Zhang, Ning Huang, Yu-Wen Li, et al.ACS Energy Letters|February 20, 2025
Single-Phase Lithiation in Iron Hydroxy Fluorides with Pyrochlore StructureJulian F Baumgärtner, Dragos C Stoian, Kenneth P Marshall, et al.Frontiers in Neuroscience|June 19, 2023
Deep-learning segmentation of fascicles from microCT of the human vagus nerveOzge N Buyukcelik, Maryse Lapierre-Landry, Chaitanya Kolluru, et al.Critical Care (London, England)|November 12, 2013
Clinical stakeholders' opinions on the use of selective decontamination of the digestive tract in critically ill patients in intensive care units: an international Delphi studyBrian H Cuthbertson, Marion K Campbell, Graeme MacLennan, et al.Journal of Multidisciplinary Healthcare|April 3, 2015
Experiences of using the Theoretical Domains Framework across diverse clinical environments: a qualitative studyCameron J Phillips, Andrea P Marshall, Nadia J Chaves, et al.The Journal of Allergy and Clinical Immunology|March 24, 2016
Relationship between lung function and quantitative computed tomographic parameters of airway remodeling, air trapping, and emphysema in patients with asthma and chronic obstructive pulmonary disease: A single-center studyRuth A Hartley, Bethan L Barker, Chris Newby, et al.European Journal of Clinical Pharmacology|March 14, 2018
Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participantsCharlotte H Maden, David Fairman, Michelle Chalker, et al.Cancer Chemotherapy and Pharmacology|March 14, 2023
Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participantsVassilios Aslanis, Robert J Slack, Alison C MacKinnon, et al.Nature Communications|March 15, 2024
Engineered dityrosine-bonding of the RSV prefusion F protein imparts stability and potency advantagesSonal V Gidwani, Devarshi Brahmbhatt, Aaron Zomback, et al.Pageof 58